Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
624 hedge funds and large institutions have $11.2B invested in Exact Sciences in 2023 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 238 increasing their positions, 204 reducing their positions, and 86 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 238 | Existing positions reduced: 204
0.54% less ownership
Funds ownership: 90.96% → 90.42% (-0.54%)
6% less call options, than puts
Call options by funds: $127M | Put options by funds: $134M
4% less funds holding
Funds holding: 652 → 624 (-28)
26% less first-time investments, than exits
New positions opened: 64 | Existing positions closed: 86
27% less capital invested
Capital invested by funds: $15.3B → $11.2B (-$4.09B)
50% less funds holding in top 10
Funds holding in top 10: 12 → 6 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$279M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$60.3M |
| 3 |
Renaissance Technologies
New York
|
+$57.6M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$35.5M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$35.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$91.6M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$74.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$69.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$69M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$63.3M |
EXAS Hedge Fund Activity: Q3 2023 in Review
624 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2023, worth a combined $11.2B — down 27% from $15.3B a quarter earlier.
Sellers outnumbered buyers: 86 funds closed out of EXAS and 64 opened new positions — a net loss of 22 holders — while 204 trimmed existing stakes and 238 added.
The largest buyer was JP Morgan Chase, adding an estimated $279M. The largest seller was Marshall Wace, exiting entirely with an estimated $91.6M sold.
- 624 institutional investors held Exact Sciences (EXAS) as of Q3 2023, down from 652 in Q2 2023.
- Funds reported $11.2B of Exact Sciences stock for Q3 2023, down 27% quarter-over-quarter.
- 64 funds opened new Exact Sciences positions in Q3 2023 and 86 closed out, a net change of -22 holders.
- The largest Exact Sciences buyer in Q3 2023 was JP Morgan Chase, an estimated $279M added.
- The largest Exact Sciences seller in Q3 2023 was Marshall Wace, an estimated $91.6M sold.
Based on aggregated 13F filings for Q3 2023.